Article
Disease-modifying therapies for T1 hypointense lesions (Black Holes) volume in patients with multiple sclerosis: Protocol for a systematic review and meta-analysis
2021-06-27
Abstract excerpt
<h4>Rationale</h4> A major part of diagnosis and follow-up in patients with multiple sclerosis is based on MRI evaluations. As T1-hypointense lesions represent neural destruction or axonal loss and anticipate irreversible disability in the patients, evaluation of the effects of Disease-modifying therapies (DMTs) on the volume of black holes seems necessary. <h4>Objectives</h4> To evaluate the effects of FDA approv...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 62feb3df-9458-56f5-b8c3-28ef3da400d3
- DOI
- 10.1101/2021.06.25.21259388
